Amgen Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
2
- Investments
-
128
- Portfolio
-
32
- Exits
-
59
Amgen Ventures General Information
Company Description
Founded in 2004, Amgen Ventures is the corporate venture capital arm of Amgen, based in Thousand Oaks, California. The firm prefers to invest in companies operating in the healthcare, life sciences, digital health, health technology, and oncology sectors across Europe and North America.
Business Details
Year Founded
Investor Status
Primary Investor Type
Corporate Office
- One Amgen Center Drive
- Thousand Oaks, CA 91320
- United States
Amgen Ventures Investments (128)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Soufflé Therapeutics | 13-Oct-2026 | Later Stage VC | Therapeutic Devices | Pre-Clinical Trials | ||
| BigHat Biosciences | 24-Sep-2026 | Drug Discovery | Clinical Trials - Phase 1 | |||
| tile.ai | 16-Sep-2026 | Database Software | Generating Revenue | |||
| Ember LifeSciences | 20-Aug-2026 | Electronic Equipment and Instruments | Generating Revenue | |||
| AAVantgarde Bio | 03-Nov-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Strand Therapeutics | 07-Aug-2025 | Drug Discovery | Clinical Trials - Phase 1 | |||
| ImmunoScape | 13-Jun-2025 | Discovery Tools (Healthcare) | Startup | |||
| Cartography Biosciences | 22-May-2025 | Drug Discovery | Clinical Trials - Phase 1 | |||
| EnClear Therapies | 03-Sep-2024 | Later Stage VC | Therapeutic Devices | Clinical Trials - General | ||
| Feldan Therapeutics | 08-Aug-2024 | Later Stage VC | Drug Delivery | Clinical Trials - Phase 1 |
Amgen Ventures Exits (59)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Culmination | 01-Nov-2026 | Out of Business | |
| Obsidian Therapeutics | 03-Aug-2026 | ||
| Quantinuum | 04-Jun-2026 | ||
| Aetion | 10-Jul-2025 | ||
| Syapse | 20-Dec-2024 | ||
| Celsius Therapeutics | 27-Jun-2024 | ||
| Cytokinetics | 24-May-2024 | ||
| Caraway Therapeutics | 20-Nov-2023 | ||
| Inversago Pharma | 08-Sep-2023 | Merger/Acquisition | |
| DJS Antibodies | 19-Oct-2022 | Merger/Acquisition |
Amgen Ventures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Amgen Ventures Co-Investors (222)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Alexandria Venture Investments | 4 |
|
|
||
| Gaingels |
|
|
|||
| MSD Global Health Innovation Fund |
|
|
|||
| Pfizer Ventures |
|
|
|||
| Polaris Partners |
|
|
Amgen Ventures FAQs
-
What is Amgen Ventures?
Founded in 2004, Amgen Ventures is the corporate venture capital arm of Amgen, based in Thousand Oaks, California.
-
When was Amgen Ventures founded?
Amgen Ventures was founded in 2004.
-
Where is Amgen Ventures headquartered?
Amgen Ventures is headquartered in Thousand Oaks, CA.
-
What is Amgen Ventures's total asset value?
Amgen Ventures has around in total assets under management.
-
How many investments has Amgen Ventures made?
Amgen Ventures has made 128 investments.
-
What has Amgen Ventures invested in?
Amgen Ventures has made numerous investments in companies like Soufflé Therapeutics, BigHat Biosciences, and tile.ai within the Therapeutic Devices, Drug Discovery, and Database Software industries.
-
What has Amgen Ventures invested in recently?
Amgen Ventures's latest investment was on 13-Oct-2026 in Soufflé Therapeutics, a company within the Therapeutic Devices industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
